CARBOHYDRATE AND LIPID METABOLIC PATHWAYS
碳水化合物和脂质代谢途径
基本信息
- 批准号:2414766
- 负责人:
- 金额:$ 34.14万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1978
- 资助国家:美国
- 起止时间:1978-05-01 至 1999-01-31
- 项目状态:已结题
- 来源:
- 关键词:carbohydrate metabolism clinical research deuterium deuterium oxide dosage enzyme activity fasting formaldehyde glucokinase gluconeogenesis glucose metabolism glycogen glycogenolysis human subject lipid metabolism liver metabolism magnetic resonance imaging method development noninsulin dependent diabetes mellitus nuclear magnetic resonance spectroscopy obesity pathologic process radiotracer
项目摘要
The long term objective is to develop and apply methods for quantitating
pathways of carbohydrate and lipid metabolism. The specific aim is to
develop a method for estimating rates of gluconeogenesis which is safe,
reliable, definitive, easily performed, and broadly applicable, an apply it
to the testing of hypotheses with regard to carbohydrate metabolism in
physiological and pathological conditions with emphasis on the diabetic
state. D2O is administered at a safe, well tolerated dose. In the fasted
state hexamethylenetetramine, formed from 6 equivalents of formaldehyde, is
used to measure the enrichment of the deuteriums bound to carbons 2,5 and
6 of glucose. Formaldehyde containing the deuterium bound to carbon 6 is
formed on periodic acid oxidation of blood glucose. Formaldehyde
containing deuterium bound to carbon 5 is formed on oxidation of xylose
formed from the glucose. Formaldehyde containing deuterium at carbon 2 is
formed by oxidation of ribitol-5-P formed from the glucose. In the fed
state, the D2O is given with acetaminophen. Deuterium bound to carbon 2
and 5 of glucose formed from the glucuronic acid moiety of the excreted
glucuronide is determined. The fraction of glucose output formed by
gluconeogenesis in the fasted state and the fraction of glycogen formation
by gluconeogenesis in the fed state, also to the ratio of the enrichment at
carbon 5 to that in body water. The carbon 5 to carbon 6 ratio is a
measure of the contribution of glycerol to gluconeogenesis and the extend
of equilibration of the hydrogens of pyruvate with those in water.
Absolute rates of gluconeogenesis in the fasted state are estimated by
multiplying the fraction via gluconeogenesis by glucose output measured
using tritiated glucose or (6,6-D2) glucose. In the fed state the quantity
of glycogen formed is measured using MRI to estimate liver volume and
13CNMR glycogen concentration. In the fasted state MRI and NMR are used to
relate estimates of rates of gluconeogenesis to rates of glycogenolysis.
Measurements will be made in normal subjects, in subjects who are obese and
in NIDDM and MODY subjects.
The findings should bear on the role of the liver in producing
hyperglycemia in the diabetic. This in turn bears on the design of
therapeutic agents and the adequacy of insulin given systemically in
returning metabolism, not just blood glucose concentration, to normal. The
approach for the first time allows the giving of D2O in safe and convenient
doses to obtain adequate labeling in glucose for measurements of the
pathways of its formation and conversion to glycogen. Because of the small
dose of deuterated water that has to be given and the small amount of
glucose that is required for analysis, the approach should be useful in
pediatric as well s adult clinical studies.
长期目标是开发和应用定量方法,
碳水化合物和脂质代谢途径。 具体目标是
开发一种安全的估计胚胎发生率的方法,
可靠,明确,易于执行,广泛适用,并应用它
关于碳水化合物代谢的假设的测试,
生理和病理条件,重点是糖尿病
状态 D2O以安全、耐受性良好的剂量给药。 在禁食
所述六亚甲基四胺由6当量甲醛形成,
用于测量与碳2,5结合的氘的富集,
6葡萄糖 含有与碳6键合的氘的甲醛是
高碘酸氧化血糖形成的。 甲醛
含有与碳5键合的氘,在木糖氧化时形成
由葡萄糖形成。 在碳2上含有氘的甲醛是
通过氧化由葡萄糖形成的核糖醇-5-P而形成。 美联储
在美国,D2O与对乙酰氨基酚一起使用。 氘与碳2结合
和5的葡萄糖形成的葡萄糖醛酸部分的排泄物
葡糖苷酸测定。 葡萄糖输出的分数由
空腹状态下的糖原生成和糖原形成分数
通过在进食状态下的异生作用,也与在
碳5在体内的含量。 碳5与碳6的比例是
甘油对植物异生作用的影响及其延伸
丙酮酸的氢与水的氢平衡。
通过以下公式估计禁食状态下新生儿的绝对速率:
将通过葡萄糖生成的分数乘以测量的葡萄糖输出
使用氚化葡萄糖或(6,6-D2)葡萄糖。 在美联储的数量
使用MRI测量形成的糖原以估计肝脏体积,
13CNMR糖原浓度。 在禁食状态下,MRI和NMR用于
将糖原生成速率的估计值与糖原分解速率相关联。
将在正常受试者、肥胖受试者和
在NIDDM和MODY受试者中。
这些发现应该与肝脏在产生
糖尿病患者的高血糖。 这反过来又影响了
治疗药物和全身给予胰岛素的充足性,
恢复新陈代谢,而不仅仅是血糖浓度,恢复正常。 的
第一次允许安全方便地给予D2O的方法
剂量,以获得足够的葡萄糖标记,用于测量
其形成和转化为糖原的途径。 因为小
剂量的氘水,必须给予和少量的
分析所需的葡萄糖,该方法应该是有用的
儿童以及成人临床研究。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
BERNARD R LANDAU其他文献
BERNARD R LANDAU的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('BERNARD R LANDAU', 18)}}的其他基金
REGULATION OF CARBOHYDRATE AND LIPID METABOLISM
碳水化合物和脂质代谢的调节
- 批准号:
2292468 - 财政年份:1994
- 资助金额:
$ 34.14万 - 项目类别:
相似海外基金
FAIRClinical: FAIR-ification of Supplementary Data to Support Clinical Research
FAIRClinical:补充数据的 FAIR 化以支持临床研究
- 批准号:
EP/Y036395/1 - 财政年份:2024
- 资助金额:
$ 34.14万 - 项目类别:
Research Grant
Optimizing integration of veterinary clinical research findings with human health systems to improve strategies for early detection and intervention
优化兽医临床研究结果与人类健康系统的整合,以改进早期检测和干预策略
- 批准号:
10764456 - 财政年份:2023
- 资助金额:
$ 34.14万 - 项目类别:
The IDeA State Consortium for a Clinical Research Resource Center: Increasing Clinical Trials in IDeA States through Communication of Opportunities, Effective Marketing, and WorkforceDevelopment
IDeA 州临床研究资源中心联盟:通过机会交流、有效营销和劳动力发展增加 IDeA 州的临床试验
- 批准号:
10715568 - 财政年份:2023
- 资助金额:
$ 34.14万 - 项目类别:
The Mayo Clinic NeuroNEXT Clinical Research Site
梅奥诊所 NeuroNEXT 临床研究网站
- 批准号:
10743328 - 财政年份:2023
- 资助金额:
$ 34.14万 - 项目类别:
Addressing Underperformance in Clinical Trial Enrollments: Development of a Clinical Trial Toolkit and Expansion of the Clinical Research Footprint
解决临床试验注册表现不佳的问题:开发临床试验工具包并扩大临床研究足迹
- 批准号:
10638813 - 财政年份:2023
- 资助金额:
$ 34.14万 - 项目类别:
Improving Multicultural Engagement in Clinical Research through Partnership with Federally Qualified Health Centers and Community Health Worker Programs
通过与联邦合格的健康中心和社区卫生工作者计划合作,改善临床研究中的多元文化参与
- 批准号:
10823828 - 财政年份:2023
- 资助金额:
$ 34.14万 - 项目类别:
The Minnesota TMD IMPACT Collaborative: Integrating Basic/Clinical Research Efforts and Training to Improve Clinical Care
明尼苏达州 TMD IMPACT 协作:整合基础/临床研究工作和培训以改善临床护理
- 批准号:
10828665 - 财政年份:2023
- 资助金额:
$ 34.14万 - 项目类别:
Promoting a Culture Of Innovation, Mentorship, Diversity and Opportunity in NCI Sponsored Clinical Research: NCI Research Specialist (Clinician Scientist) Award Application of Janice M. Mehnert, M.D.
在 NCI 资助的临床研究中促进创新、指导、多样性和机会文化:Janice M. Mehnert 医学博士的 NCI 研究专家(临床科学家)奖申请
- 批准号:
10721095 - 财政年份:2023
- 资助金额:
$ 34.14万 - 项目类别:
Clinical Research Center for REstoration of NEural-based Function in the Real World (RENEW)
现实世界神经功能恢复临床研究中心 (RENEW)
- 批准号:
10795328 - 财政年份:2023
- 资助金额:
$ 34.14万 - 项目类别:
Clinical Research and Academic Success in Obstetrics & Gynecology
产科临床研究和学术成就
- 批准号:
10828252 - 财政年份:2023
- 资助金额:
$ 34.14万 - 项目类别:














{{item.name}}会员




